SCHEMBL29650209

SCHEMBL29650209

Oc1cccc(SC2CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CA2 P00918 2/20 0.44
CYP3A4 P08684 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
LMNA P02545 1/20 0.44
CA5A P35218 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
HSD17B1 P14061 3/20 0.37
HSD17B2 P37059 3/20 0.37
MGLL Q99685 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C9 P11712 1/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19692875 1.00 CA12 (0.44) CA12ALDH1A1CA2CYP3A4CA9
Hydrochloric Acid SCHEMBL6882791 0.79 DRD2 (0.40) CA12ALDH1A1CA2CYP3A4CA9
SCHEMBL29711729 0.75 DDB1 (0.51) ALDH1A1MAOAMAOBMGLLGRIK1
SCHEMBL15271053 0.75 DDB1 (0.51) ALDH1A1MAOAMAOBACHE
SCHEMBL2416364 0.75 DDB1 (0.51) ALDH1A1MAOAMAOBMGLLGRIK1
SCHEMBL15720972 0.75 CYP3A4 (0.44) CA12ALDH1A1CA2CYP3A4CA9
SCHEMBL24837521 0.75 MAOA (0.34) MAOAMAOBGRIK1GRIA2OPRM1
SCHEMBL30288394 0.75 DDB1 (0.55) MAOAMAOBTSHRGRIK1GRIA2
SCHEMBL19277423 0.75 DDB1 (0.55) MAOAMAOBTSHRGRIK1GRIA2
SCHEMBL6436876 0.75 TYR (0.45) ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed